- Release Date: 06/05/20 10:13
- Summary: First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS
- Price Sensitive: No
- Download Document 128.22KB
Ann: First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS
- There are more pages in this discussion • 188 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.015(1.40%) |
Mkt cap ! $1.238B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.10 | $1.07 | $3.778M | 3.482M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 32734 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 58309 | 11 |
View Market Depth
| Last trade - 15.11pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.10 |
Change
0.015 ( 2.82 %) |
||||
| Open | High | Low | Volume | ||
| $1.09 | $1.10 | $1.07 | 626215 | ||
| Last updated 15.24pm 21/05/2024 ? | |||||
| MSB (ASX) Chart |